Correlation Between Keros Therapeutics and Aadi Bioscience

Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Aadi Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Aadi Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Keros Therapeutics and Aadi Bioscience, you can compare the effects of market volatilities on Keros Therapeutics and Aadi Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Aadi Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Aadi Bioscience.

Diversification Opportunities for Keros Therapeutics and Aadi Bioscience

-0.75

Correlation Coefficient

Keros Therapeutics  Aadi Bioscience

Pay attention - limited upside

The 3 months correlation between Keros and Aadi is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Aadi Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aadi Bioscience and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Aadi Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aadi Bioscience has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Aadi Bioscience go up and down completely randomly.

Pair Corralation between Keros Therapeutics and Aadi Bioscience

Given the investment horizon of 90 days Keros Therapeutics is expected to generate 0.91 times more return on investment than Aadi Bioscience. However, Keros Therapeutics is 1.1 times less risky than Aadi Bioscience. It trades about -0.01 of its potential returns per unit of risk. Aadi Bioscience is currently generating about -0.02 per unit of risk. If you would invest  4,986  in Keros Therapeutics on October 7, 2024 and sell it today you would lose (3,376) from holding Keros Therapeutics or give up 67.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Keros Therapeutics  vs.  Aadi Bioscience

Keros Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Keros Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Aadi Bioscience

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aadi Bioscience are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental indicators, Aadi Bioscience demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Keros Therapeutics and Aadi Bioscience

The main advantage of trading using opposite Keros Therapeutics and Aadi Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Aadi Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aadi Bioscience will offset losses from the drop in Aadi Bioscience's long position.

The idea behind Keros Therapeutics and Aadi Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.